Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 2. [21-Asparagine diethylamide-A]insulin

• Published in: Biochemistry (Easton) 1987-11, Vol.26 (22), p.6972-6975
• Main Authors: Chu, Ying Chi, Burke, G. Thompson, Chanley, Jacob D, Katsoyannis, Panayotis
• Format: Article
• Language: English
• Subjects: Animals; Hydrolysis; Indicators and Reagents; Insulin - analogs & derivatives; Insulin - chemical synthesis; Insulin - pharmacology; Macromolecular Substances; Sheep
• ISSN: 0006-2960; 1520-4995
• DOI: 10.1021/bi00396a017

We have synthesized [21-asparagine diethylamide-A]insulin, which differs from the parent molecule in that the free carboxyl group of the C-terminal amino acid residue, asparagine, of the A chain moiety has been converted to a diethylamide group. The analogue displays equivalent potency in receptor binding and biological activity, 48% and 56%, respectively, relative to bovine insulin. In contrast, we have reported previously [Burke, G. T., Chanley, J. D., Okada, Y., Cosmatos, A., Ferderigos, N., & Katsoyannis, P. G. (1980) Biochemistry 19, 4547-4556] that [21-asparaginamide-A]insulin exhibits a divergence in these properties, ca. 60% in receptor binding and ca. 13% in biological activity. The disparity in the biological behavior of these analogues is discussed, and we ascribe the modulation of biological activity independent of receptor binding activity observed between these analogues to the difference in the negativity of the carbonyl oxygen of the A chain moiety C-terminal amino acid residue.